The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...

Tom Williams is using his experience to encourage others to register as organ donors, calling 2025 his best year since a life ...

Crown Princess Mette-Marit of Norway is expected to undergo a lung transplant as testing indicated a "clear worsening" of her ...

Burbine is married to well-known country music musician and singer David Burbine, who was inducted into the Nova Scotia ...

Marit, wife of future king, Crown Prince Haakon of Norway is to go under the knife for a rare pulmonary fibrosis issue and ...

"I have always hoped that we would be able to keep the disease in check with medication, and the development has actually ...

The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...

The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...